The Food and Drug Administration's commissioner is facing congressional lawmakers for the first time over the national shortage of baby formula
Earlier this week, the FDA announced several steps to address the problem, including a preliminary agreement with formula maker Abbott Nutrition to reopen its plant, which has been shuttered since February due to contamination.
Rep. Rosa DeLauro, D-Conn., pointed to a recently released whistleblower complaint alleging numerous safety violations at Abbott's plant, including employees falsifying records and failing to properly test formula before releasing it. She said the former Abbott employee alerted the FDA to the situation in October but was not interviewed by agency staff until late December.
There are other questions about the FDA's timeline for dealing with Abbott. The company shut its Michigan plant in February after FDA inspectors began investigating four bacterial infections in infants who had consumed formula from the plant. The first of those cases was reported to the FDA in September though agency staff didn't begin inspecting the facility until late January.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
U.S. lawmakers unveil FDA emergency funds bill to address baby formula shortageU.S. House Democrats on Tuesday unveiled a bill to provide $28 million in emergency funds to the Food and Drug Administration (FDA) to help it respond to a nationwide shortage of infant formula and strengthen supervision of the industry.
Weiterlesen »
Massie slams FDA and USDA, blames them for baby formula and meat shortagesRep. Thomas Massie blamed the FDA and USDA for baby formula and meat shortages, saying they contribute to the high prices and lack of supply.
Weiterlesen »
FDA greenlights nonprescription test for Covid, flu and RSVDo I have Covid or the flu?: FDA greenlights nonprescription, at-home test that can detect Covid, influenza A and B, and RSV.
Weiterlesen »
FDA authorizes Pfizer-BioNTech booster shots for kids 5-11The FDA has authorized booster doses of the Pfizer-BioNTech COVID-19 vaccine for kids 5-11.
Weiterlesen »
FDA clears COVID booster shot for healthy kids ages 5 to 11U.S. regulators on Tuesday authorized a COVID-19 booster shot for healthy 5- to 11-year-olds, hoping an extra vaccine dose will enhance their protection as infections once again creep upward.
Weiterlesen »